Literature DB >> 2614445

Anti-Purkinje cell cytoplasmic and neuronal nuclear antibodies aid diagnosis of paraneoplastic autoimmune neurological disorders.

V A Lennon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2614445      PMCID： PMC1031609          DOI： 10.1136/jnnp.52.12.1438

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Subacute sensory neuronopathy associated with small cell lung carcinoma: diagnosis aided by autoimmune serology.

Authors:  D W Kimmel; B P O'Neill; V A Lennon
Journal:  Mayo Clin Proc       Date:  1988-01       Impact factor: 7.616

2.  Anti-Purkinje cell antibodies are specific for small-cell lung cancer but not for paraneoplastic neurological disorders.

Authors:  W Grisold; M Drlicek; U Liszka; W Popp
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

3.  Neuronal anti-nuclear antibody in paraneoplastic sensory neuronopathy.

Authors:  D J Dick; J B Harris; G Falkous; J B Foster; J H Xuereb
Journal:  J Neurol Sci       Date:  1988-05       Impact factor: 3.181

4.  Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes.

Authors:  J L Smith; J C Finley; V A Lennon
Journal:  J Neuroimmunol       Date:  1988-04       Impact factor: 3.478

5.  Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.

Authors:  M Rodriguez; L I Truh; B P O'Neill; V A Lennon
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

6.  Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.

Authors:  N E Anderson; M K Rosenblum; F Graus; R G Wiley; J B Posner
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

7.  Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration.

Authors:  J Cunningham; F Graus; N Anderson; J B Posner
Journal:  Neurology       Date:  1986-09       Impact factor: 9.910

8.  Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.

Authors:  K A Jaeckle; F Graus; A Houghton; C Cardon-Cardo; S L Nielsen; J B Posner
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

9.  Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma.

Authors:  J E Greenlee; H R Brashear
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422
  9 in total
  5 in total

1.  Circulating antineuronal antibodies reach neurons in vivo: an autopsy study.

Authors:  M Drlicek; U Liszka; K Jellinger; A Mohn-Staudner; F Lintner; W Grisold
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

2.  Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon.

Authors:  T Tsukamoto; R Mochizuki; H Mochizuki; M Noguchi; H Kayama; M Hiwatashi; T Yamamoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

3.  CSF herpes virus and autoantibody profiles in the evaluation of encephalitis.

Authors:  Jenny J Linnoila; Matthew J Binnicker; Masoud Majed; Christopher J Klein; Andrew McKeon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-06-01

Review 4.  Paraneoplastic neurological complications of breast cancer.

Authors:  Ibrahim Fanous; Patrick Dillon
Journal:  Exp Hematol Oncol       Date:  2016-10-24

Review 5.  CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases.

Authors:  Christos Liaskos; Eirini I Rigopoulou; Timoklia Orfanidou; Dimitrios P Bogdanos; Christos N Papandreou
Journal:  Clin Dev Immunol       Date:  2013-04-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.